Crinetics Pharmaceuticals (NASDAQ: CRNX) 30-day option implied volatility is at 66; compared to its 52-week range of 42 to 92. Call put ratio 13.7 calls to 1 put into Vertex Pharmaceuticals Incorporated (VRTX) acquiring CRNX.